Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

5.16.11.reconstructive urology


Published on

  • Be the first to comment

  • Be the first to like this

5.16.11.reconstructive urology

  1. 1. EMBARGOED FOR RELEASE UNTIL MONDAY, MAY 16, 2011 AT 8:00 A.M. Contact: Wendy Waldsachs Isett, AUA 410-977-4770, RESEARCHERS ADVANCE TREATMENTS FOR INCONTINENCE DUE TO SPINAL CORD DEFECTS, DISEASE AND DEFORMED BLADDERSWashington, DC, May 16, 2011– Employing a variety of the most sophisticated experimental techniquesand procedures, researchers have advanced treatments for children in need of bladder reconstruction. Anew study, presented during a special press conference at the Walter E. Washington Convention Center inWashington, DC on May 16, 2011 at 8:00 a.m. during the 106th Annual Scientific Meeting of the AmericanUrological Association (AUA), outlines a new technique using a demucosalized stomach flap as anautograft supplement in gastrocystoplasty.A stomach flap is commonly used as an autograft supplement in gastrocystoplasty for pediatric bladderreconstruction. However, two main problems arise when using this tissue: the stomach mucosa causesmany complications when an entire stomach flap is used; and the stomach graft contracts if ademucosalized stomach flap is used. Researchers investigated the use of a demucosalized stomach flapcovered with bladder cell-seeded small intestinal submucosa and whether botulinum toxin A, used fortreating severe bladder spasticity, could be used to prevent contraction of the flap.The study, led by researchers at the University of Oklahoma Science Health Center, was completed in 10adult beagle dogs weighing 10 -12 Kg. All of the dogs survived and their gastric grafts were all viable with agood blood supply. All the stomach flap grafts contracted 10 weeks after surgery. However, those thatwere treated with bladder cell-seeded SIS and Botox A injection contracted significantly less,demonstrating a potential clinical use in bladder reconstruction via gastrocytoplasty. “Being able to use a patient’s own cells to regenerate and re-grow tissue to treat disease is truly aremarkable step forward in medicine,” said session moderator Anthony Atala, MD, an AUA spokespersonand recognized world leader in the area of tissue regeneration. “These new techniques help minimize risksof rejection and the need for immunosuppressants, while providing a return to normal control andfunction.”NOTE TO REPORTERS: Experts are available to discuss this study outside normal briefing times. Toarrange an interview with an expert, please contact the AUA Communications Office at the numberabove or e-mail the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, theAmerican Urological Association is the pre-eminent professional organization for urologists, with more than 17,000members throughout the world. An educational nonprofit organization, the AUA pursues its mission of fostering thehighest standards of urologic care by carrying out a wide variety of programs for members and their patients. ###
  2. 2. 1189RE-EPITHELIZATION OF A DEMUCOSALIZED STOMACH PATCH WITH UROTHELIAL CELLS SEEDED SMALLINTESTINE SUBMUCOSA IN BLADDER AUGMENTATIONYuanyuan Zhang, GuiHua Liu, Kropp BP, Winston-Salem, NCINTRODUCTION AND OBJECTIVES: A pedicle stomach flap is commonly used as an autograft supplementin gastrocystoplasty for pediatric bladder reconstruction. However, two main problems arise when usingstomach flaps: 1). the stomach mucosa causes many complications when an entire stomach flap is usedand 2) the stomach graft contracts if a demucosalized stomach flap is used. Botulium Toxin A (Botox A) iswidely used for treating severe bladder spasticity. This study is designed to evaluate the possibility ofusing a demucosalized stomach flap covered with bladder cell-seeded small intestinal submucosa (SIS) forgastrocystoplasty and to determine whether an injection of Botox A into the re-urothelized stomach flapcould protect the graft from contraction in a canine bladder reconstruction model.METHODS: Ten adult beagle dogs weighing from 10-12 Kg were used. The animals were divided into fivegroups. Gastrocystoplasty was performed using entire stomach flaps as a control (n=2, Group I). The othergroups consisted of animals repaired with demucosalized stomach flaps alone (n=2, Group II),demucosalized flaps covered with unseeded SIS (n=2, Group III), demucosalized flaps covered with bladdercell (urothelial and smooth muscle cells) seeded SIS (n=2, Group IV) and demucosalized flaps with bladdercell-seeded SIS combined with an injection of Botox A (10 units /ml, 50 units) (n=2, Group V). The grafttissue samples were examined histologically and with immunohistochemistry ten weeks aftergastrocystoplasty.RESULTS: All dogs survived and their gastric grafts were all viable with a good blood supply. Urothelium(metaplasia) appeared on the top of the stomach mucosa flaps in two animals in Group I. A calicification atthe center of one graft was found in an animal in Group II. The stomach flaps were partially covered withurothelium in Groups II and III, and stratified urothelium completely covered the de-mucosalized gastricflaps in Groups IV and V. Although all stomach flap grafts contracted ten weeks after surgery, the stomachgrafts in Groups I and V showed less contraction (half the original size). In contrast, the stomach grafts inGroups II, III, and IV significantly contracted to one quarter of the original size.CONCLUSIONS: Bladder cell-seeded SIS promotes complete urothelial regeneration on demucosalizedstomach flap grafts. Botox A injection appears to protect the graft from contraction. Combination both ofthese techniques has a potential clinical use in bladder reconstruction via gastrocystoplasty.Source of Funding: none